SS&C Technologies Holdings Inc at RBC Capital Markets FinTech Conference Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Matt Roswell - RBC Capital Markets - Analyst : So I guess this is sort of the first question is, you recently moved some businesses between your verticals. Can you give us a 30-second sort of overview of the new verticals, what's in each vertical, who it serves, etc.?

Question: Matt Roswell - RBC Capital Markets - Analyst : Now can we take each one of those verticals and get the core products and customers, competitors?

Question: Matt Roswell - RBC Capital Markets - Analyst : Leaving healthcare aside for a second, what does demand look like? And are you competing against other vendors, other suppliers? Or are you competing against financial institutions, sort of in-house developed?

Question: Matt Roswell - RBC Capital Markets - Analyst : Okay. One of the questions we get asked a lot is your revenue exposure to asset valuation levels. Market goes down, market goes up. How does that run through the business model?

Question: Matt Roswell - RBC Capital Markets - Analyst : Okay. Switching gears a little bit, getting away from financial services for a little bit. Blue Prism, you mentioned that it's about half the business you're sort of using in house.

Question: Matt Roswell - RBC Capital Markets - Analyst : Okay, and this is an unfair question or a tough question. You bought it. There was a debate as to whether it made more sense to continue to sell it to clients outside or it actually having a bigger impact on SS&C itself. We're now, what, 2.5 years, 3 years since the acquisition?

Question: Matt Roswell - RBC Capital Markets - Analyst : Thank you. Where do we come in?

Question: Matt Roswell - RBC Capital Markets - Analyst : And again, if I'm remembering correctly, when you bought it, it had a fairly significant percentage of non-financial services clients. Have they stuck with the company?

Question: Matt Roswell - RBC Capital Markets - Analyst : Makes sense. Healthcare, how does it fit in?

Question: Matt Roswell - RBC Capital Markets - Analyst : So is margin potential similar to the other businesses?

Question: Matt Roswell - RBC Capital Markets - Analyst : You mentioned DomaniRx. It's a partnership, correct?

Question: Matt Roswell - RBC Capital Markets - Analyst : With Humana?

Question: Matt Roswell - RBC Capital Markets - Analyst : Why did you want to partner with them, or did they partner with you? I mean, who's bringing what to the relationship? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JUNE 11, 2024 / 5:20PM, SSNC.OQ - SS&C Technologies Holdings Inc at RBC Capital Markets FinTech Conference

Question: Matt Roswell - RBC Capital Markets - Analyst : You mentioned the problems that one of your competitors had with their cyberattack. Are there other major competitors or are the insurance companies mainly doing it themselves?

Question: Matt Roswell - RBC Capital Markets - Analyst : I've got plenty more questions, but I want to open it up to the room if there's anything out there. More crickets. We had some crickets this morning and more crickets now. There's been a question around SS&C in terms of organic growth versus inorganic growth and whether there's trade-offs between the two or something to cause organic growth to come in disappointing in some years better than others. You're relatively new. What do you see coming in in terms of that dynamic, and any possible changes that you would think about?

Question: Matt Roswell - RBC Capital Markets - Analyst : Speaking of that M&A, as you look at the portfolio, are there pieces that don't make sense anymore? And are there holes that you're looking to fill?

Question: Matt Roswell - RBC Capital Markets - Analyst : Okay. We're pushing up on time, so my last question, SS&C has a great track record of boosting margins. We talked earlier about how Blue Prism is helping you continue to do that. Before Blue Prism, what was the secret sauce and where can the margins go?

Question: Matt Roswell - RBC Capital Markets - Analyst : It sounds a lot like just blocking and tackling.

Question: Matt Roswell - RBC Capital Markets - Analyst : Okay. Well, thank you. Appreciate it.